Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial.

MLA

Martin, Alan, et al. “Is Single-Inhaler Triple Therapy for COPD Cost-Effective in the UK? The IMPACT Trial.” ERJ Open Research, vol. 8, no. 1, Feb. 2022. EBSCOhost, https://doi.org/10.1183/23120541.00333-2021.

APA

Martin, A., Shah, D., Ndirangu, K., Anley, G. A., Okorogheye, G., Schroeder, M., Risebrough, N., & Ismaila, A. S. (2022). Is single-inhaler triple therapy for COPD cost-effective in the UK? The IMPACT trial. ERJ Open Research, 8(1). https://doi.org/10.1183/23120541.00333-2021

Chicago

Martin, Alan, Dhvani Shah, Kerigo Ndirangu, Glenn A Anley, Gabriel Okorogheye, Melanie Schroeder, Nancy Risebrough, and Afisi S Ismaila. 2022. “Is Single-Inhaler Triple Therapy for COPD Cost-Effective in the UK? The IMPACT Trial.” ERJ Open Research 8 (1). doi:10.1183/23120541.00333-2021.